Endocan levels in acute diverticulitis
Part of Digestive system clinical trials.
This study aims to see if levels of a protein called endocan in your blood can help doctors understand acute diverticulitis better. By participating, you will have your blood tested and be followed to help improve future care for this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with acute diverticulitis (confirmed by an ultrasound or CT scan)
- You are willing to sign a consent form to participate
- You do not have a weakened immune system
- You do not have a long-term inflammatory disease (like rheumatoid arthritis or lupus)
- You do not have cancer, heart failure, severe kidney disease, or severe liver disease
- You have not had major surgery on a large blood vessel (like for an aneurysm)
- You are not pregnant
- You are not taking part in other studies that might interfere
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests MBK-01, capsules made from healthy gut bacteria, to see if they can help people who keep getting diverticulitis. If you've had three or more bouts in the last three years, this study might offer a new treatment option.
This study looks at how the bacteria in your gut might be related to diverticular disease (pouches in your colon). If you have had diverticulitis, researchers want to see if your gut microbiome is different from people without the condition.
This study tests whether some patients with mild diverticulitis (inflammation in the colon) can recover without antibiotics, using rest and supportive care instead. If it works, it could help avoid unnecessary antibiotics and their side effects.
This trial tests if mild diverticulitis (a small infection in the colon) can be safely treated at home without antibiotics. If you have this condition and are otherwise healthy, you may be able to avoid a hospital stay.
This study looks at whether certain blood markers can help measure disease activity in people with Crohn's disease or ulcerative colitis. It involves reviewing medical records and may include a colonoscopy if you have one done as part of your routine care.
This study looks for specific body signals (called mitochondrial “DAMPs”) that may reflect active inflammation in Crohn’s disease and ulcerative colitis. It also checks how these markers relate to what doctors see during colonoscopy or flexible scope exams, to help understand inflammation and potentially guide future care.
Hear when a new Diverticulitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.